Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Global First: NHSE unveils 'Artificial Pancreas' for type 1 Diabetes patients across England

Global First: NHSE unveils 'Artificial Pancreas' for type 1 Diabetes patients across England

NHSE has outlined a comprehensive 5-year implementation strategy to ensure equitable access to Artifical pancreas 

The National Health Services England (NHSE) is poised to revolutionise diabetes management with the introduction of the 'artificial pancreas', also known as the Hybrid Closed Loop system, to treat type 1 diabetes. This pioneering initiative, endorsed by the National Institute of Health Care and Excellence (NICE), represents a global first in healthcare innovation.


With 269,095 individuals grappling with type 1 diabetes in England, the Hybrid Closed Loop system is set to cater to tens of thousands of children and adults across the nation.

This cutting-edge device operates by seamlessly monitoring blood glucose levels and autonomously adjusting insulin dosage through a pump, by eliminating the need for regular insulin injections.

Furthermore, it holds the promise of averting life-threatening hypoglycaemic and hyperglycaemia episodes, mitigating significant risks associated with the condition.

To facilitate the identification of beneficiaries, NHSE has allocated a substantial sum of £2.5 million, ensuring that those who could benefit from this innovative solution receive the necessary support.

This initiative follows a successful pilot programme that equipped 835 adults and children with type 1 diabetes, resulting in significant enhancements to their condition management.

Dr Clare Hambling, National Clinical Director for diabetes, voiced optimism regarding the transformative impact of this initiative, projecting improvements in both the quality of life and clinical outcomes for individuals with type 1 diabetes across England.

Further, she underscored the importance of recognising symptoms such as increased urination, excessive thirst, fatigue, and unexplained weight loss, urging timely intervention for diagnosis.

Professor Partha Kar, NHS national speciality advisor for diabetes, lauded the Hybrid Closed Loop systems for their ability to enhance medical care and elevate the overall quality of life for recipients.

She said," the device detects your glucose levels, transmits the readings to the delivery system, known as the pump, which then initiates the process of determining the required insulin dosage."

With the endorsement from the National Institute of Health Care and Excellence (NICE), NHS England has laid out a comprehensive 5-year implementation strategy, ensuring equitable access to the Hybrid Closed Loop system.

Moreover, Health Minister Andrew Stephenson hailed the introduction of the technology as a significant step towards simplifying diabetes management and improving outcomes for individuals with type 1 diabetes.

"People living with type 1 diabetes face the constant stress of needing to monitor their blood glucose levels to stay healthy and avoid complications."

"This new technology will ease the burden on patients and allow them to manage their condition more easily, without needing to draw blood or wear a continuous glucose monitor," he added.

The rollout of the artificial pancreas has garnered widespread praise from recipients, with many attesting to its transformative impact on their lives calling it "a game changer" and hassle-free to use.

More For You

St James's University Hospital , NHS

Care Quality Commission downgraded the maternity and neonatal services at St James's University Hospital and Leeds General Infirmary.

Getty images

Two Leeds maternity units downgraded after inspection

The NHS regulator has downgraded two hospitals in Leeds to "inadequate" from "good" following an inspection.

The Care Quality Commission (CQC) said the maternity and neonatal services at Leeds General Infirmary (LGI) and St James' University Hospital of the Leeds Teaching Hospitals (LTH) NHS Trust posed "a significant risk" to women and babies.

Keep ReadingShow less
Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Primary care leaders join forces in effort to 'transform investment into primary care'

Community Pharmacy England (CPE) has teamed up with other national primary care bodies to urge the government to allocate more funds towards the sector.

In a joint statement released on the back of the government’s spending review, last week, the organisations welcomed the government’s continued determination to ‘shift care from hospitals to community and from sickness to prevention’ but warned that this would not be possible ‘without further investment in primary care’.

Keep ReadingShow less
Cancer patients warned against using weight-loss jabs

Macmillan Cancer Support said there is not enough evidence on how the weight-loss jabs might affect anti-cancer treatments.

iStock

Cancer patients warned against using weight-loss jabs

Cancer patients have been advised to consult their doctor before taking any weight-loss jabs.

Macmillan Cancer Support has issued this advisory following a surge in calls by cancer patients asking whether they can take fat loss jabs such as Wegovy and Mounjaro.

Keep ReadingShow less
Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology

The FLOWRx auto hub in the new Kamson warehouse in Uckfield.

Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology


Kamsons Pharmacy has announced that it has implemented a state-of-the-art hub and spoke dispensing model with the aim of freeing up more time to deliver clinical services.

Keep ReadingShow less
RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less